Newsroom

Recent news, statements, and resources

Newsroom

Recent news, statements, and resources

Welcome to The Leukemia & Lymphoma Society Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

Join LLS in supporting patients in Ukraine

Join Us in Supporting Childhood Cancer Patients in Ukraine

March 7, 2022

FDA Approval Misc.

FDA Approves New Drug for Patients with Rare Blood Cancer (Myelofibrosis)

March 1, 2022

Bike for Breakthroughs

The Leukemia & Lymphoma Society’s Newest Event Aims to Power Groundbreaking Research and Support for Cancer Patients

February 2, 2022

The US Capitol

New Poll: Americans Believe It’s Time to Protect Consumers From Predatory Short-Term Health Plans

January 24, 2022

Burlington Stores’ 20th Consecutive In-Store Fundraising Campaign Raises Nearly $3.4 Million for The Leukemia & Lymphoma Society

January 18, 2022

News Article 1.4.22

LLS Statement on COVID-19 Omicron Variant for Blood Cancer Patients and Survivors

January 4, 2022

Misc. Cell

FDA Approves First Drug for The Prevention of Acute Graft Versus Host Disease

December 22, 2021

Banner Image

Largest Study to Date Demonstrates Most Blood Cancer Patients Benefit From a Third Primary Dose of mRNA COVID-19 Vaccine

December 13, 2021

Beat AML

Study in Nature Medicine Shows Superior Outcomes for Patients in LLS's Paradigm-Shifting Beat AML Clinical Trial

October 22, 2020

Media Requests

For all media-related inquiries and interview requests please email mediarelations@lls.org. An LLS representative will respond as soon as possible.